Dermapharm Holding SE annual gross margin
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Dermapharm Holding SE Gross Margin Growth & History (DMP)
Dermapharm Holding SE's gross margin was 67.04% for fiscal 2025.
View full Dermapharm Holding SE company overviewDermapharm Holding SE annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 67.04% | +3.80 pp |
| 2024 | 2024-12-31 | 63.24% | +1.55 pp |
| 2023 | 2023-12-31 | 61.69% | −1.86 pp |
| 2022 | 2022-12-31 | 63.55% | −1.07 pp |
| 2021 | 2021-12-31 | 64.62% | +10.47 pp |
| 2020 | 2020-12-31 | 54.16% | +3.17 pp |
| 2019 | 2019-12-31 | 50.98% | +1.14 pp |
| 2018 | 2018-12-31 | 49.84% | +4.71 pp |
| 2017 | 2017-12-31 | 45.13% | +2.00 pp |
| 2016 | 2016-12-31 | 43.13% | −0.76 pp |
| 2015 | 2015-12-31 | 43.90% | +4.48 pp |
| 2014 | 2014-12-31 | 39.42% | — |
Dermapharm Holding SE gross margin trends
Over the last five fiscal years, Dermapharm Holding SE's gross margin increased from 54.16% to 67.04%, a change of +12.88 percentage points.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as reported gross profit divided by reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Dermapharm Holding SE source filings ↗